West Pharmaceutical Services, I Price Today
West Pharmaceutical Services, I
WST
Healthcare
$28.74B
💰
Market Cap
49.8
💸
Price to Earnings
$7.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
4 |
Strong Buy |
5 |
Hold |
4 |
Sell |
0 |
Strong Sell |
0 |
WST Price Forecast Target
392.6 👉 470.0 +20%
WST EPS Forecast
7.9 👉 9.1 +15%
Financials
Profit Margin
20 %
Revenue Growth
3.3 %
Dividend
$ 0.8
Held Percent
0.6% - Insiders
95.9% - Institutions
3.5% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…📮FAQ
Some Frequently Asked Questions.
The West Pharmaceutical Services, I industry is Medical Instruments & Supplies
The West Pharmaceutical Services, I sector is Healthcare
The West Pharmaceutical Services, I forecasted predicted Price to Earnings PE ratio is 43.4
The West Pharmaceutical Services, I Price to Earnings PE ratio is 49.8
The Market Capitalization of West Pharmaceutical Services, I is $28.74B
There are total of 72815521 float shares with 95.9% held by Institutions and 0.6% held by insiders
The MWest Pharmaceutical Services, I forecasted Earnings per Share EPS is $9.1
The West Pharmaceutical Services, I Earnings per Share EPS is 7.9
The West Pharmaceutical Services, I company has $0 gross profits with 20 profit margins
The West Pharmaceutical Services, I Earnings Growth is 0.334% with 0.33% quarterly earnings growth
The West Pharmaceutical Services, I Revenue is $2949799936 with 0.033 revenue growth
The price target for West Pharmaceutical Services, I stock is $470.0 for the high target and $355.0 for the low target
The consensus analyst recommendations for West Pharmaceutical Services, I is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for West Pharmaceutical Services, I is Buy, with the following breakdown:
- Buy: 4
- Strong Buy: 5
- Hold: 4
- Sell: 0
- Strong Sell: 0
The Beta of West Pharmaceutical Services, I is 1.0
The dividend of West Pharmaceutical Services, I is $0.8
The dividend yield of West Pharmaceutical Services, I is 0.002%
The biggest institutional and mutual fund holders of West Pharmaceutical Services, I stock are
The West Pharmaceutical Services, I ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0